Daiichi Sankyo Espha Set to Push Drug Adherence for Cancer AGs, Boost Added Value for Generics

Daiichi Sankyo Espha President Kentaro Murakawa Daiichi Sankyo Espha is working to ramp up drug adherence for its authorized generics (AGs) in the oncology arena, while at the same time boosting added values to non-AG generics, which will hold the...read more